Curaleaf Holdings, Inc. (TSX:CURA)

Curaleaf Holdings Statistics

Total Valuation

TSX:CURA has a market cap or net worth of CAD 4.25 billion. The enterprise value is 5.67 billion.

Market Cap	4.25B
Enterprise Value	5.67B

Important Dates

The last earnings date was Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:CURA has 792.18 million shares outstanding. The number of shares has increased by 3.60% in one year.

Current Share Class	698.21M
Shares Outstanding	792.18M
Shares Change (YoY)	+3.60%
Shares Change (QoQ)	+2.57%
Owned by Insiders (%)	1.75%
Owned by Institutions (%)	3.45%
Float	668.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.37
PB Ratio	3.35
P/TBV Ratio	n/a
P/FCF Ratio	54.40
P/OCF Ratio	25.29
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.94, with an EV/FCF ratio of 72.70.

EV / Earnings	-31.38
EV / Sales	3.16
EV / EBITDA	14.94
EV / EBIT	241.44
EV / FCF	72.70

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 1.15.

Current Ratio	1.56
Quick Ratio	0.60
Debt / Equity	1.15
Debt / EBITDA	3.83
Debt / FCF	18.62
Interest Coverage	0.17

Financial Efficiency

Return on equity (ROE) is -8.74% and return on invested capital (ROIC) is 0.93%.

Return on Equity (ROE)	-8.74%
Return on Assets (ROA)	0.37%
Return on Invested Capital (ROIC)	0.93%
Return on Capital Employed (ROCE)	0.67%
Weighted Average Cost of Capital (WACC)	11.80%
Revenue Per Employee	323,139
Profits Per Employee	-32,561
Employee Count	5,554
Asset Turnover	0.45
Inventory Turnover	2.80

Taxes

Income Tax	-12.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +346.67% in the last 52 weeks. The beta is 1.63, so TSX:CURA's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	+346.67%
50-Day Moving Average	3.59
200-Day Moving Average	3.59
Relative Strength Index (RSI)	67.19
Average Volume (20 Days)	1,257,254

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CURA had revenue of CAD 1.79 billion and -180.84 million in losses. Loss per share was -0.23.

Revenue	1.79B
Gross Profit	883.22M
Operating Income	23.50M
Pretax Income	-126.25M
Net Income	-180.84M
EBITDA	296.58M
EBIT	23.50M
Loss Per Share	-0.23

Balance Sheet

The company has 148.14 million in cash and 1.45 billion in debt, with a net cash position of -1.31 billion or -1.65 per share.

Cash & Cash Equivalents	148.14M
Total Debt	1.45B
Net Cash	-1.31B
Net Cash Per Share	-1.65
Equity (Book Value)	1.27B
Book Value Per Share	1.47
Working Capital	230.56M

Cash Flow

In the last 12 months, operating cash flow was 167.87 million and capital expenditures -89.82 million, giving a free cash flow of 78.05 million.

Operating Cash Flow	167.87M
Capital Expenditures	-89.82M
Depreciation & Amortization	267.30M
Net Borrowing	-23.90M
Free Cash Flow	78.05M
FCF Per Share	0.10

Margins

Gross margin is 49.21%, with operating and profit margins of 1.31% and -7.79%.

Gross Margin	49.21%
Operating Margin	1.31%
Pretax Margin	-7.03%
Profit Margin	-7.79%
EBITDA Margin	16.53%
EBIT Margin	1.31%
FCF Margin	4.35%

Dividends & Yields

TSX:CURA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.60%
Shareholder Yield	-3.60%
Earnings Yield	-4.26%
FCF Yield	1.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CURA has an Altman Z-Score of 0.29 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.29
Piotroski F-Score	7